Japan Tissue Engineering Co., Ltd. announced earnings guidance for the fiscal year ending March 31, 2022. For the full Fiscal Year, the company expects sales of JPY 2,260 million, Operating loss of JPY 450 million, net loss of JPY 449 million and net loss per share of JPY 11.06.
Japan Tissue Engineering Co., Ltd.
Equities
7774
JP3389610001
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
660 JPY | 0.00% | +0.92% | +30.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.24% | 170M | |
+13.16% | 128B | |
-8.76% | 10.65B | |
+3.60% | 8.82B | |
+19.75% | 7.19B | |
+22.28% | 4.99B | |
+7.55% | 3.4B | |
-0.21% | 3.03B | |
-4.80% | 2.14B | |
-4.72% | 2B |
- Stock Market
- Equities
- 7774 Stock
- News Japan Tissue Engineering Co., Ltd.
- Japan Tissue Engineering Co., Ltd. Announces Earnings Guidance for the Fiscal Year Ending March 31, 2022